Study of high-altitude polycythemia
Part of Blood & lymphatic clinical trials.
This study looks at high-altitude polycythemia, a condition where your body makes too many red blood cells because of living at high altitude. Researchers want to learn more about it, so they are inviting people with this condition to participate.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with high-altitude polycythemia (a condition where your body makes too many red blood cells due to living at high altitude).
- You are 18 years old or older.
- You agree to take part in the study and sign a consent form.
- You are not currently confused or unconscious.
- You do not have severe bleeding in your stomach or intestines, and you can breathe and eat normally without risk of choking.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a treatment called remote ischemic conditioning (using a blood pressure cuff to briefly stop blood flow in your arm, which is thought to protect the body) to see if it can help people with high-altitude polycythemia, a condition where your body makes too many red blood cells because of the thin air at high altitudes.
This study looks at how the right side of the heart responds to low oxygen levels in people who have had high altitude pulmonary edema (HAPE) in the past. It will help researchers better understand right heart function.
This trial tests new ways to diagnose and treat severe altitude sickness, which can cause fluid in the lungs or swelling in the brain. It aims to improve care for people who get very sick after climbing to high altitudes quickly.
This study looks at how the heart and lungs respond when people with pulmonary hypertension travel from low to high altitude. It may help doctors understand how to better care for patients living at high altitudes.
This trial tests whether high-flow oxygen (delivered through a special nasal tube) works better than standard oxygen therapy for a condition called high-altitude pulmonary edema (HAPE)—fluid buildup in the lungs caused by rapid ascent to high altitude. The study aims to see which approach helps patients breathe better and recover faster.
This trial tests if Advair HFA affects how likely someone is to develop High Altitude Pulmonary Edema (HAPE), a serious lung condition at high altitudes. It compares people who are prone to HAPE, those who are resistant, and healthy controls.
Hear when a new High-altitude Polycythemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.